Retractable Technologies Inc.

Retractable Technologies Inc., a Little Elm, Texas-based for-profit medical device manufacturer, supplies safety syringes and needles to federal health agencies and the U.S. military as a prime contractor across 428 awards (98% of recent activity) and competes full-and-open without set-aside designations. The company manufactures VanishPoint low dead space syringes and related medical injection devices designed to reduce needlestick injury risks, operating from a facility in Oak Point, Texas, with registered federal contracting activity since May 2001.

Retractable Technologies' federal customer base is heavily concentrated around a single transformational contract. The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response dominates the potential-value ranking with a $388.1 million award (representing 96% of the vendor's combined $403.1 million potential value across all 436 awards) — this was a major 2021 COVID-19 response contract referenced across multiple award summaries. Beyond that anchor, the vendor's active pipeline is shaped by high-frequency, low-value purchase orders: the Defense Logistics Agency Troop Support Medical accounts for 136 awards but carries only $54 thousand combined potential value, reflecting routine syringes-and-needles replenishment ordering patterns. The Department of Health and Human Services Indian Health Service and the Office of the Assistant Secretary for Administration each hold 18 awards with combined potential values of $117 thousand and $132 thousand respectively. The vendor serves 13 distinct customer agencies total; the gap between volume concentration (42% of awards across the top five customers) and dollar concentration (the HHS ASPR contract alone anchors nearly all potential value) signals Retractable Technologies' dual posture as both a steady-state consumables supplier to DLA and other routine medical purchasers and the beneficiary of a single massive pandemic-response award.

Vehicle position is split between high-frequency small orders and larger IDCs. The Federal Supply Schedule V797P4819A carries 255 task orders with only $406 thousand combined potential value, reflecting the vendor's GSA Schedule seat as a channel for small direct purchases and agency ordering. The Indefinite Delivery Contract 75A50118D00012 (3 task orders, $93.9 million combined potential value) and IDC SPE2DM20D2008 and SPE2DM20D9007 (2 task orders each) appear to anchor the COVID-19-era and successor volume. A single-award Blanket Purchase Agreement with the Department of Veterans Affairs Veterans Integrated Service Network 1, awarded May 15, 2024, with a ceiling value of one dollar and running through July 14, 2030, enables streamlined procurement of VanishPoint low dead space syringes at VA facilities within VISN 1.

Activity has accelerated in recent years — 17 awards in 2022, 17 in 2023, 19 in 2024, and 39 in 2025 — driven by the high-frequency DLA ordering pattern. The vendor has obligated $212.2 million (53% of combined potential value) across these awards, indicating substantial revenue realization. In its marginal subcontractor role (2% of recent awards), Retractable Technologies delivers medical and surgical equipment and supplies to Cardinal Health 200, LLC as a sub-supplier; representative sub awards include a patient holding room kit for Madigan Army Medical Center (December 2024), an adult infusion system (August 2024), and a hypothermia kit (December 2023).

The vendor's primary NAICS footprint is Surgical and Medical Instrument Manufacturing (402 of 436 awards), with secondary activity in Surgical Appliance and Supplies Manufacturing (17 awards) and Medical, Dental, and Hospital Equipment Merchant Wholesaling (9 awards). PSC coding mirrors this: Medical And Surgical Instruments, Equipment, And Supplies represents 397 of the awards. Retractable Technologies' federal posture centers on commodity medical device supply — low-value, high-frequency orders from DLA Troop Support and VA, anchored historically by a single large pandemic-response contract. The company does not compete under SBA set-asides and maintains no major prime teaming relationships; its subcontract footprint is narrow and flows through Cardinal Health.